InnoPharmax Inc. (TPEX:4172)

Taiwan · Delayed Price · Currency is TWD

18.35

+3.80 (26.12%)

Apr 20, 2026, 1:20 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Design, Development, Production and Manufacturing of Pharmaceuticals		32.30M	46.07M	29.13M	48.06M	136.88M
Design, Development, Production and Manufacturing of Pharmaceuticals Growth		-29.90%	58.15%	-39.38%	-64.89%	61.24%
Total		32.30M	46.07M	29.13M	48.06M	136.88M
Total Growth		-29.90%	58.15%	-39.38%	-64.89%	61.24%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan		23.38M	28.56M	29.13M	40.59M	36.73M
Taiwan Growth		-18.14%	-1.98%	-28.23%	10.50%	35.30%
Mainland China		8.92M	16.54M	-	3.58M	97.26M
Mainland China Growth		-46.07%	-	-	-96.32%	75.03%
Others		-	979.00K	-	3.89M	2.89M
Others Growth		-	-	-	34.81%	32.80%
Total		32.30M	46.07M	29.13M	48.06M	136.88M
Total Growth		-29.90%	58.15%	-39.38%	-64.89%	61.24%

Source: S&P Global Market Intelligence.